Randal W. Scott sold $755K of BridgeBio Pharma (BBIO)

Executed Feb 17, disclosed Feb 18, 1 day later.

Value, as filed

$755K

10,000 sh across 3 lots

Executed

Feb 17

the trade date, as filed

Disclosed

Feb 18

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Randal W. Scott Director profile →

Randal W. Scott (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $755K of BBIO (10,000 sh across 3 lots, as filed), executed Feb 17.

The name

BBIO

BridgeBio Pharma, Inc. BBIO · Healthcare · 71 filings in 24 months ticker →

Healthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Randal W. Scott in BBIO

BBIOSALE BridgeBio Pharma, Inc. $658K
9,800 sh across 3 lots
Exec May 15
Filed May 19 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $666K
10,000 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET